Bevacizumab for Intravitreal Injection: Impact of Sub-Visible Particles on the Shelf-Life of Repackaged Bevacizumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bevacizumab for Intravitreal Injection: Impact of Sub-Visible Particles on the Shelf-Life of Repackaged Bevacizumab

Published:2019-07 Issue:6 Volume:35 Page:372-375
ISSN:1080-7683
Container-title:Journal of Ocular Pharmacology and Therapeutics
language:en
Short-container-title:Journal of Ocular Pharmacology and Therapeutics

Author:

Crul Mirjam¹,Zandvliet Anthe²,Moes Jan Reindert³,Veenbaas Tjitske⁴,Smeets Oscar⁵

Affiliation:

1. Department of Clinical Pharmacology and Pharmacy, Amsterdam University Medical Center, Amsterdam, the Netherlands.

2. Department of Clinical Pharmacy, OLVG, Amsterdam, the Netherlands.

3. Department of Clinical Pharmacy, Martini Hospital, Groningen, the Netherlands.

4. Department of Clinical Pharmacy, Albert Schweitzer Hospital, Dordrecht, the Netherlands.

5. Laboratorium der Nederlandse Apotheken (LNA), Royal Dutch Pharmacy Association (KNMP), the Hague, the Netherlands.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmacology,Ophthalmology

Link

https://www.liebertpub.com/doi/pdf/10.1089/jop.2019.0042

Reference26 articles.

1. Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration

2. Effect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion

3. Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

4. Sustained elevation of intraocular pressure after intravitreal injections of bevacizumab in eyes with neovascular age-related macular degeneration

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Post Manufacturing Handling of Protein-Based Biologic Drugs on Product Quality and User Centricity;Journal of Pharmaceutical Sciences;2024-08

2. Faricimab maintains substance integrity and sterility after compounding and storage in two different polypropylene syringe types;2024-04-29

3. Evidence-Based Use of Bevacizumab in the Management of Neovascular Age-Related Macular Degeneration;Ophthalmic Surgery, Lasers and Imaging Retina;2024-03

4. Physicochemical and Biological Stability Assessment of SB11 (Ranibizumab Biosimilar) Under Ambient and In-Use Storage for Intravitreal Administration;Ophthalmology and Therapy;2023-01-06

5. Incidence of ocular hypertension after anti-VEGF injections: examining the effect of drug filtration and silicone-free syringes;Canadian Journal of Ophthalmology;2021-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3